The drawbacks of GLP-1 medications It may seem like everyone is taking GLP-1 agonists
There was a notable link between GLP-1 treatments and hair thinning: a 37 percent higher risk compared to SGLT-2 inhibitors, and a 68 percent higher risk compared to DPP-4 inhibitors
Once-weekly formulations like semaglutide reach steady-state concentrations after approximately 45 weeks, while dulaglutide typically reaches steady state in 24 weeks
It's all labeled for "research use only." Alongside reta, he lists another not-yet-for-sale drug from Novo Nordisk, called cagrilintide, or cagri, and a popular concoction: cagri-reta, blending two in-development GLP-1s from two different drugmakers
So, basically, its a medication that helps a building block of proteins that is like glucagon work as it should in the body
The trials did not show dramatic muscle loss in well-nourished participants, but this was not the primary outcome measured, and individual dietary behaviour varies significantly outside controlled trial conditions
